Dare Bioscience, Inc. (DARE) Q4 2024 Annual Earnings
DARE·Reported March 31, 2025·After market close
Dare Bioscience, Inc. reported Q4 2024 revenue of -$63.6K, missed analyst consensus of $1.0M by $1.1M. Diluted EPS came in at $-0.64, beat the $-0.66 consensus by $0.02.
Revenue
-$63.6Kmissed by $1.1M
Consensus: $1.0MDiluted EPS
$-0.64beat by $0.02
Consensus: $-0.66
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Dare Bioscience, Inc.'s Q4 2024 earnings report.
Dare Bioscience, Inc. (DARE) reported Q4 2024 earnings on March 31, 2025 after market close.
Dare Bioscience, Inc. reported revenue of -$63.6K and diluted EPS of $-0.64 for Q4 2024.
Revenue missed the consensus estimate of $1.0M by $1.1M. EPS beat the consensus estimate of $-0.66 by $0.02.
You can read the 10-K periodic report (0001401914-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.